FdaApplication
ANDA 206223
Identifiers
- fda_app_no: ANDA206223
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2018-01-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE | EQ 5MG BASE/VIAL | INJECTABLE;INJECTION |
| REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE | EQ 2MG BASE/VIAL | INJECTABLE;INJECTION |
| REMIFENTANIL HYDROCHLORIDE | REMIFENTANIL HYDROCHLORIDE | EQ 1MG BASE/VIAL | INJECTABLE;INJECTION |
3 products